Market Place
Sourcing Support
Acer Receives Notice of Allowance of Key US Patent Application Covering EDSIVO
26 Oct 2022 //
GLOBENEWSWIRE
Acer Therapeutics` EDSIVO Granted FDA BTD for Vascular Ehlers-Danlos Syndrome
04 Apr 2022 //
GLOBENEWSWIRE
Acer Therapeutics Restructures Company, Eliminates 29 Employees
08 Jul 2019 //
BIOSPACE
FDA kicks back Acer`s rare disease drug, demands new test—shares in freefall
26 Jun 2019 //
FIERCE BIOTECH
FDA rejects Acer`s rare disease drug, asks for new trial
24 Jun 2019 //
ENDPTS
FDA accepts Acer, Kala NDAs before funding lapse
02 Jan 2019 //
BIOCENTURY
Acer Therapeutics Closes $8.15 Million Series B Financing
10 May 2016 //
BUSINESS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.